Primary endpoints were area under the plasma concentration-time curve from 0 to 72 hours ( AUC0-72 ) and maximum plasma concentration ( Cmax ) for linagliptin , and AUC from 0 to the last quantifiable concentration ( AUC0-tz ) and Cmax for metformin .